XML 221 R32.htm IDEA: XBRL DOCUMENT v3.25.2

Statements of Operations-Additional Information (Tables)

12 Months Ended

Jun. 30, 2025

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type

​	​	​	​	​	​	​	​	​	​
​		​		​	​		​	​
For the Year Ended June 30	​	2025		​	2024		​	2023
Animal Health	​	​			​		​	​	​
MFAs and other	​	$	646,354	​	$	420,959	​	$	387,349
Nutritional specialties	​		179,289	​		164,671	​	​	172,504
Vaccines	​		137,153	​		120,852	​	​	99,998
Total Animal Health	​	$	962,796	​	$	706,482	​	$	659,851
Mineral Nutrition	​		253,240	​		243,663	​	​	242,656
Performance Products	​		80,179	​		67,534	​	​	75,382
Total	​	$	1,296,215	​	$	1,017,679	​	$	977,889

​

Net Sales by Region

​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​	​	​
For the Year Ended June 30	​	2025			2024			2023
United States	​	$	739,919	​	$	584,763	​	$	578,773
Latin America and Canada	​		298,649	​		247,705	​	​	219,846
Europe, Middle East and Africa	​		160,232	​		121,977	​	​	117,815
Asia Pacific	​		97,415	​		63,234	​	​	61,455
Total	​	$	1,296,215	​	$	1,017,679	​	$	977,889

Schedule of interest expense, net

​

​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​	​	​
For the Year Ended June 30	​	2025			2024			2023
Interest expense, net	​	​	​	​	​	​	​	​	​
Credit Facilities	​	$	32,779	​	$	20,646	​	$	17,302
2022 Term loan	​	​	12	​	​	862	​	​	589
Amortization of debt issuance costs	​		2,015	​		1,040	​		727
Refinancing expense	​	​	1,960	​	​	—	​	​	—
Other	​		458	​		462	​		58
Interest expense	​		37,224	​		23,010	​		18,676
Interest income	​		(2,622)	​		(4,474)	​		(3,355)
​	​	$	34,602	​	$	18,536	​	$	15,321

Schedule of depreciation and amortization

​

​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​	​	​
For the Year Ended June 30		2025			2024			2023
Depreciation and amortization	​		​	​		​	​
Depreciation of property, plant and equipment	​	$	37,762	​	$	26,517	​	$	24,316
Amortization of intangible assets	​		7,843	​		9,661	​		9,696
​	​	$	45,605	​	$	36,178	​	$	34,012

Schedule of amortization of intangible assets

​

​	​	​	​
For the Years Ending June 30		​
2026	​	$	6,789
2027	​		6,416
2028	​		6,205
2029	​		6,205
2030	​		4,805
Thereafter	​		6,048
Total	​	$	36,469

Schedule of research and development expense

​

​	​	​	​	​	​	​	​	​	​
For the Year Ended June 30		2025			2024			2023
Research and development expense	​	$	23,726	​	$	29,194	​	$	24,395

X

- Definition

Tabular disclosure of depreciation and amortization.

+ References

No definition available.

+ Details

Name:	pahc_ScheduleOfDepreciationAndAmortizationTableTextBlock
Namespace Prefix:	pahc_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of interest expense, net.

+ References

No definition available.

+ Details

Name:	pahc_ScheduleOfInterestExpenseNetTableTextBlock
Namespace Prefix:	pahc_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of research and development expense.

+ References

No definition available.

+ Details

Name:	pahc_ScheduleOfResearchAndDevelopmentExpenseTableTextBlock
Namespace Prefix:	pahc_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_IncomeStatementRelatedDisclosuresAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

+ Details

Name:	us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration